KIF20B与LUAD进展相关,是独立的风险因素
Jianye Yang1, Liang Xu2, Xiaoliang Han1
1Affiliated Hospital of Shaoxing University (The Shaoxing Municipal Hospital).
Critical reviews in eukaryotic gene expression
|February 2, 2024
概括
高素家族成员20B (KIF20B) 表达表明肺腺癌 (LUAD) 的预后不佳. 抑制KIF20B可能是抑制LUAD进展的有价值策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 素家族蛋白 (KIFs) 涉及到人类瘤的发生.
- 素家族成员20B (KIF20B) 在肺腺癌 (LUAD) 中的作用需要进一步调查.
研究的目的:
- 为了研究KIF20B在LUAD中的表达.
- 确定KIF20B与LUAD进展和患者预后的关联.
主要方法:
- 分析了来自535名LUAD患者 (TCGA) 的RNA-seq数据.
- 在瘤与对照组织以及疾病不同阶段的KIF20B表达的比较.
- 使用si-KIF20B.进行生存分析,Cox回归和体外实验 (A549细胞).
主要成果:
- 在LUAD组织和晚期阶段,KIF20B的上调.
- 高KIF20B表达与较短的存活率相关,是独立的风险因素.
- 抑制KIF20B减少了A549细胞的细胞迁移/侵入,增加了A549细胞的亡,影响了p53,Bax和Bcl-2的表达.
结论:
- 升高的KIF20B表达是LUAD中预后不佳的独立预测因素.
- 向KIF20B为LUAD治疗提供了一个潜在的治疗策略.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...


